Business
Annual General Meeting 2021 - Change of Venue
Annual General Meeting 2021 - Change of Venue.
About this update from Skinbiotherapeutics Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 3762W\n SkinBioTherapeutics PLC\n 21 December 2021\n \n \n \n \n 21 December 2021\n \n \n \n \n \n SkinBioTherapeutics plc\n \n \n \n \n \n \n \n Annual General Meeting 2021 - Change of Venue\n \n \n \n SkinBioTherapeutics plc (the \"Company\") announced its full year audited results for the year to 30 June 2021 on 30 November 2021, including notice that the Company's Annual General Meeting (\"AGM\") would be held at The Core, Bath Lane, Newcastle Helix, Newcastle upon Tyne, NE4 5TF on 23 December 2021 at 11.00 am.\n \n \n \n \n \n As set out in the notes to the Notice of Annual General Meeting included in the Annual Report for the year ended 30 June 2021 published on 30 November 2021, shareholders have been asked not to attend the meeting and to appoint the Chairman of the meeting as their proxy to attend and vote at the meeting. In respect of the evolving Coronavirus (COVID-19) situation and in accordance with the Company's articles of association, the Board has resolved that the venue of the AGM will be moved to 21 College Court, Macclesfield, SK11 8HN.\n \n \n \n \n \n All other details as advised in the Notice of Annual General Meeting remain the same.\n \n \n \n \n \n -Ends-\n \n \n For more information please contact:\n \n \n \n \n \n \n SkinBioTherapeutics plc\n \n \n Stuart J\n . Ashman, CEO\n \n \n Doug Quinn, CFO\n \n \n \n \n Tel: +44 (0) 161 468 2760\n \n \n \n \n \n \n \n Cenkos Securities Plc \n \n (Nominated Adviser & Broker)\n \n \n Giles Balleny, Max Gould (Corporate Finance)\n \n \n Michael Johnson, Dale Bellis (Sales)\n \n \n \n \n Tel: +44 (0) 20 7397 8900\n \n \n \n \n \n \n Instinctif Partners (financial press)\n \n \n Melanie Toyne-Sewell / Nathan Billis \n \n \n \n \n Tel: +44 (0) 20 7457 2020\n \n \n \n [email protected]\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n About SkinBioTherapeutics plc\n \n \n SkinBioTherapeutics is a life science company focused on skin health. The Company's proprietary platform technology, SkinBiotix®, is based upon discoveries made by Professor Catherine O'Neill and Professor Andrew McBain. \n \n \n The Company is targeting a number of skin healthcare sectors, the most advanced of which are cosmetic skincare and food supplements to modulate the immune system by harnes...